Alfasigma acquires the European license for bentracimab from PhaseBio

— The agreement covers the countries of the European Union, the European Economic Area, the United Kingdom, Ukraine, Russia and the CIS — Bentracimab is a human monoclonal antibody fragment to counteract the antiplatelet effects of ticagrelor — After the recent acquisition of Lumeblue®, Alfasigma’s pipeline is enriched with a biotechnological drug Alfasigma has entered into […]

thaipr.net

22 มิ.ย. 64

RedHill Biopharma Announces Presentation of Positive Oral Opaganib Phase 2 Data in COVID-19

Positive U.S. Phase 2 safety and efficacy data for opaganib, a leading novel, oral, dual-mechanism drug candidate for moderate-to-severe COVID-19, presented at the World Microbe Forum Opaganib was associated with a reduction in the need for supplemental oxygen support, earlier time to discharge from hospital and was well tolerated Opaganib’s global 475-patient Phase 2/3 study […]

thaipr.net

22 มิ.ย. 64

INDICAID(R) COVID-19 Rapid Antigen Test certified by Cambodia’s Ministry of Health for Disease Control

Cambodia’s Ministry of Health has approved INDICAID® COVID-19 Rapid Antigen Test for commercialisation as part of the country’s efforts in controlling recent spikes of COVID-19 cases in the region. Rapid antigen tests like INDICAID® have been deployed by the Cambodian Government for widescale screening measures in the capital city Phnom Penh and neighbouring regions, taking […]

thaipr.net

22 มิ.ย. 64

EAN Congress: COVID-19 leads to significant cognitive and behavioural problems in patients

COVID-19 patients suffer from cognitive and behavioural problems two months after being discharged from hospital, a new study presented at the 7th Congress of the European Academy of Neurology has found [1]. Issues with memory, spatial awareness and information processing problems were identified as possible overhangs from the virus in post-COVID-19 patients who were followed up […]

thaipr.net

21 มิ.ย. 64

World less peaceful as civil unrest and political instability increases due to COVID-19 pandemic, reveals IEP

Today marks the launch of the 15th edition of the Global Peace Index from the international think-tank the Institute for Economics & Peace (IEP). Key results Civil unrest rose globally by 10%, with Belarus recording the largest deterioration. There were 14,871 violent demonstrations, protests and riots recorded globally in 2020. Over 60% of people globally are worried about […]

thaipr.net

17 มิ.ย. 64

Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial

– 93% efficacy against predominantly circulating Variants of Concern and Variants of Interest– 91% efficacy in high-risk populations– 100% efficacy against variants “not considered Variants of Concern/Interest”– All COVID-19 hospitalizations/death occurred in the placebo group– Company to host investor conference call today at 8:30 am ET Novavax, Inc. (Nasdaq: NVAX), today announced that NVX-CoV2373, its…

thaipr.net

15 มิ.ย. 64
1 115 116 117 118 119 136